2026 POSTER PRESENTATIONS
Preliminary List as of February 6, 2026
Bachem Americas, Inc.
Large-Scale Manufacturing of siRNA by Enzymatic Ligation
Forge Biologics, a member of Ajinomoto Bio-Pharma Services
Expediting the Development of Antibody-Oligonucleotide Conjugates (AOCs) by AJICAP® Conjugation Technology
FreeThink Technologies, Inc.
Accelerated Stability Assessment Program (ASAP) for the Rapid Determination of Shelf Life for Oligonucleotides
Immuneed AB
Prediction of Clinical Immunotoxicity of Oligonucleotide Therapeutics Using an Ex Vivo Test System with Circulating Human Whole Blood
Kodiak Sciences, Inc.
High-DAR Antibody Biopolymer Conjugate Drug (ABCD) for Therapeutic Oligonucleotide Delivery
Mitsubishi Gas Chemical Company, Inc.
Separation of N-1mer Using the Reversible Interaction Between Boronic Acid and Diols
WuXi AppTec
An Integrated Service Platform Supporting ASO Drug Discovery: A Technology Showcase for the Design, Synthesis, In Vitro Screening and In Vivo Validation of ATXN2-Targeting ASOs
WuXi AppTec
DNA-Encoded Libraries and Display Technologies Empower Early Discovery of Peptide Drugs and Peptide-Based Delivery Tools